Press release
Global Transmucosal Drug Delivery Devices Market Projected to Surpass $78.21 Billion by 2029 with 9.2% Annual Growth
Transmucosal Drug Delivery Devices Market
""What combination of drivers is leading to accelerated growth in the transmucosal drug delivery devices market?
The growing prevalence of chronic diseases is expected to accelerate the growth of the transmucosal drug delivery devices market. Chronic diseases are long-lasting conditions that often require ongoing medical management. The rise in chronic diseases is influenced by factors like lifestyle choices, aging populations, environmental influences, healthcare system challenges, and urbanization. Transmucosal drug delivery devices are used to provide controlled and efficient medication delivery for managing chronic diseases, helping to ensure sustained therapeutic levels and improved patient adherence. For instance, in August 2023, the Leukemia & Lymphoma Society reported that in the U.S., approximately every three minutes, someone is diagnosed with leukemia, lymphoma, or myeloma. In 2023, an estimated 184,720 new cases were expected, representing 9.4% of the projected 1,958,310 new cancer cases for the year. As a result, the increasing prevalence of chronic diseases is driving the growth of the transmucosal drug delivery devices market.
Get Your Transmucosal Drug Delivery Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report
What is the projected compound annual growth rate (CAGR) of the transmucosal drug delivery devices market from 2025 to 2034, and what factors influence it?
The transmucosal drug delivery devices market has expanded significantly. It is projected to rise from $50.24 billion in 2024 to $55.04 billion in 2025, with a CAGR of 9.6%. The market's past growth was influenced by the need for rapid angina relief, the effectiveness of sublingual drug delivery for quick bloodstream absorption, the advantage of bypassing gastrointestinal degradation, the development of buccal tablets, and the increasing preference for non-invasive peptide and protein delivery.
The market for transmucosal drug delivery devices is projected to experience significant growth in the coming years, reaching $78.21 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. Factors driving this growth include advancements in smart drug delivery systems, a rising prevalence of chronic illnesses, an increasing focus on personalized medicine, an aging population with greater medication needs, and growing awareness. Key trends during the forecast period include expanding therapeutic applications, the customization of drug delivery devices for personalized treatments, regulatory approvals, emerging markets, eco-friendly devices, and innovative formulations.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
How are the latest trends influencing the growth of the transmucosal drug delivery devices market?
In the transmucosal drug delivery devices market, companies are developing proprietary transdermal patch delivery platforms to improve drug absorption and patient convenience. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology company, launched STARSILON, a proprietary transdermal patch delivery platform. This innovative platform offers sustained drug delivery for challenging active pharmaceutical ingredients (APIs), enhancing therapeutic efficacy over longer periods.
What are the major segments of the transmucosal drug delivery devices market and their role in driving growth?
The transmucosal drug delivery devices market covered in this report is segmented -
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812
Which regions are key players in the growth of the transmucosal drug delivery devices market?
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the transmucosal drug delivery devices market?
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
What Is Covered In The Transmucosal Drug Delivery Devices Global Market Report?
•Market Size Forecast: Examine the transmucosal drug delivery devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the transmucosal drug delivery devices market for a structured understanding.
•Key Players Overview: Analyze major players in the transmucosal drug delivery devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the transmucosal drug delivery devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the transmucosal drug delivery devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the transmucosal drug delivery devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the transmucosal drug delivery devices market.
•Competitive Landscape: Review strategic developments in the transmucosal drug delivery devices market, including expansions, agreements, and new product launches."
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Transmucosal Drug Delivery Devices Market Projected to Surpass $78.21 Billion by 2029 with 9.2% Annual Growth here
News-ID: 3940499 • Views: …
More Releases from The Business research company
Road Maintenance Market Expected to Achieve 5.7% CAGR by 2029: Growth Forecast I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Road Maintenance Market Size By 2025?
In recent times, there has been a significant increase in the size of the road maintenance market. It's projected to expand from $14.55 billion in 2024 to $15.34 billion in 2025, with a compound annual growth rate (CAGR) of…
Navigating the Future: Aggregate In Road Construction Market Trends and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Aggregate In Road Construction Market Size Growth Forecast: What to Expect by 2025?
The total market size for aggregate in road construction has seen a swift surge in the past few years. It is projected to rise from $828.16 billion in 2024 to reach $928.75 billion in 2025, with…
Technological Advancements In Low-Carbon Construction Materials Industry Trends …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Low Carbon Construction Materials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been a robust growth in the size of the low carbon construction materials market in recent years, expanding from $259.42 billion in 2024 to an expected $281.84 billion in 2025. This…
Impact Of Increasing Construction Activities On The Crane And Hoist Market: Stre …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Crane And Hoist Market Through 2025?
In recent times, there has been a consistent increase in the size of the crane and hoist market. Anticipated growth is from $32.33 billion in 2024 to $33.81 billion in 2025, representing a compound annual growth…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
